{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:13:33Z","timestamp":1783707213567,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11912-019-0795-1","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T09:09:18Z","timestamp":1555492158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia"],"prefix":"10.1007","volume":"21","author":[{"given":"Kartik","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly","family":"Niravath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"issue":"10001","key":"795_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","volume":"386","author":"R Bradley","year":"2015","unstructured":"Bradley R, Burrett J, Clarke M, Davies C, Duane F, Evans V, et al. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386(10001):1341\u201352.","journal-title":"Lancet."},{"key":"795_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0093-7754(03)00302-6","volume":"30","author":"WR Miller","year":"2003","unstructured":"Miller WR. Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer. Semin Oncol. 2003;30:3\u201311.","journal-title":"Semin Oncol"},{"key":"795_CR3","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","volume":"25","author":"KD Crew","year":"2007","unstructured":"Crew KD, Greenlee H, Capodice J, Raptis G, Brafman L, Fuentes D, et al. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol. 2007;25:3877\u201383.","journal-title":"J Clin Oncol"},{"key":"795_CR4","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/annonc\/mdt037","volume":"24","author":"P Niravath","year":"2013","unstructured":"\u2022 Niravath P. Aromatase inhibitor-induced arthralgia: a review. Ann Oncol. 2013;24:1443\u20139 This review paper nicely summarizes the diagnosis, risk factors, and treatment of aromatase inhibitor-induced arthralgia.","journal-title":"Ann Oncol"},{"key":"795_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S1470-2045(08)70182-7","volume":"9","author":"I Sestak","year":"2008","unstructured":"Sestak I, Cuzick J, Sapunar F, Eastell R, Forbes JF, Bianco AR, et al. Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis. Lancet Oncol. 2008;9:866\u201372.","journal-title":"Lancet Oncol"},{"key":"795_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4174\/jkss.2013.85.5.205","volume":"85","author":"JY Park","year":"2013","unstructured":"Park JY, Lee SK, Bae SY, Kim J, Kim MK, Kil WH, et al. Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors. J Korean Surg Soc. 2013;85:205.","journal-title":"J Korean Surg Soc"},{"key":"795_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/NCC.0b013e31824a7e18","volume":"36","author":"A Boonstra","year":"2013","unstructured":"Boonstra A, Van Zadelhoff J, Timmer-Bonte A, Ottevanger PB, Beurskens CHG, Van Laarhoven HWM. Arthralgia during aromatase inhibitor treatment in early breast cancer patients: prevalence, impact, and recognition by healthcare providers. Cancer Nurs. 2013;36:52\u20139.","journal-title":"Cancer Nurs"},{"key":"795_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jpainsymman.2012.10.282","volume":"46","author":"D Fenlon","year":"2013","unstructured":"Fenlon D, Addington-Hall JM, O\u2019Callaghan AC, Clough J, Nicholls P, Simmonds P. A survey of joint and muscle aches, pain, and stiffness comparing women with and without breast cancer. J Pain Symptom Manag. 2013;46:523\u201335.","journal-title":"J Pain Symptom Manag"},{"key":"795_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","volume":"134","author":"CC Murphy","year":"2012","unstructured":"Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon SW. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat. 2012;134:459\u201378.","journal-title":"Breast Cancer Res Treat"},{"key":"795_CR10","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1200\/JCO.2011.38.0261","volume":"30","author":"NL Henry","year":"2012","unstructured":"Henry NL, Azzouz F, Desta Z, Li L, Nguyen AT, Lemler S, et al. Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol. 2012;30:936\u201342.","journal-title":"J Clin Oncol"},{"key":"795_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/01.SMJ.0000140834.30654.0F","volume":"98","author":"VS Sierpina","year":"2005","unstructured":"Sierpina VS, Frenkel MA. Acupuncture: A clinical review. South Med J. 2005;98:330\u20137.","journal-title":"South Med J"},{"key":"795_CR12","first-page":"710750","volume":"2012","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Lao L, Chen H, Ceballos R. Acupuncture use among american adults: what acupuncture practitioners can learn from national health interview survey 2007? Evidence-based Complement Altern Med. 2012;2012:710750.","journal-title":"Evidence-based Complement Altern Med"},{"key":"795_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/1529-0131(200104)44:4<819::AID-ANR138>3.0.CO;2-P","volume":"44","author":"J Ezzo","year":"2001","unstructured":"Ezzo J, Hadhazy V, Birch S, Lao L, Kaplan G, Hochberg M, et al. Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis Rheum. 2001;44:819\u201325.","journal-title":"Arthritis Rheum"},{"key":"795_CR14","doi-asserted-by":"publisher","first-page":"e0151882","DOI":"10.1371\/journal.pone.0151882","volume":"11","author":"HD Lim","year":"2016","unstructured":"Lim HD, Kim MH, Lee CY, Namgung U. Anti-inflammatory effects of acupuncture stimulation via the vagus nerve. PLoS One. 2016;11:e0151882.","journal-title":"PLoS One"},{"key":"795_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0965-2299(97)80008-8","volume":"5","author":"J Sims","year":"1997","unstructured":"Sims J. The mechanism of acupuncture analgesia: a review. Complement Ther Med. 1997;5:102\u201311.","journal-title":"Complement Ther Med"},{"key":"795_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00421-003-0825-3","volume":"90","author":"M Sandberg","year":"2003","unstructured":"Sandberg M, Lundeberg T, Lindberg LG, Gerdle B. Effects of acupuncture on skin and muscle blood flow in healthy subjects. Eur J Appl Physiol. 2003;90:114\u20139.","journal-title":"Eur J Appl Physiol"},{"key":"795_CR17","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1200\/JCO.2009.23.4708","volume":"28","author":"KD Crew","year":"2010","unstructured":"Crew KD, Capodice JL, Greenlee H, Brafman L, Fuentes D, Awad D, et al. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol. 2010;28:1154\u201360.","journal-title":"J Clin Oncol"},{"key":"795_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/acupmed-2012-010309","volume":"31","author":"B Oh","year":"2013","unstructured":"Oh B, Kimble B, Costa DSJ, Davis E, McLean A, Orme K, et al. Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study. Acupunct Med. 2013;31:264\u201371.","journal-title":"Acupunct Med"},{"key":"795_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10549-013-2427-z","volume":"138","author":"T Bao","year":"2013","unstructured":"Bao T, Cai L, Giles JT, Gould J, Tarpinian K, Betts K, et al. A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors. Breast Cancer Res Treat. 2013;138:167\u201374.","journal-title":"Breast Cancer Res Treat"},{"key":"795_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejca.2013.09.022","volume":"50","author":"JJ Mao","year":"2014","unstructured":"Mao JJ, Xie SX, Farrar JT, Stricker CT, Bowman MA, Bruner D, et al. A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use. Eur J Cancer. 2014;50:267\u201376.","journal-title":"Eur J Cancer"},{"key":"795_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jama.2018.8907","volume":"320","author":"DL Hershman","year":"2018","unstructured":"\u2022\u2022 Hershman DL, Unger JM, Greenlee H, Capodice JL, Lew DL, Darke AK, et al. Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer a randomized clinical trial. JAMA - J Am Med Assoc. 2018. This paper is the largest trial of acupuncture for aromatase inhibitor-induced arthralgia with 3 arms: acupuncture, sham acupuncture, and waitlist control group.;320:167\u201376.","journal-title":"JAMA - J Am Med Assoc"},{"key":"795_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/acm.2015.0184","volume":"22","author":"H MacPherson","year":"2016","unstructured":"MacPherson H, Hammerschlag R, Coeytaux RR, Davis RT, Harris RE, Kong J-T, et al. Unanticipated insights into biomedicine from the study of acupuncture. J Altern Complement Med. 2016;22:101\u20137.","journal-title":"J Altern Complement Med"},{"key":"795_CR23","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1001\/jama.2017.7217","volume":"317","author":"XK Wu","year":"2017","unstructured":"Wu XK, Stener-Victorin E, Kuang HY, Ma HL, Gao JS, Xie LZ, et al. Effect of acupuncture and clomiphene in Chinese women with polycystic ovary syndrome: a randomized clinical trial. JAMA - J Am Med Assoc. 2017;317:2502.","journal-title":"JAMA - J Am Med Assoc"},{"key":"795_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.pain.2006.12.006","volume":"128","author":"K Linde","year":"2007","unstructured":"Linde K, Witt CM, Streng A, Weidenhammer W, Wagenpfeil S, Brinkhaus B, et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain. 2007;128:264\u201371.","journal-title":"Pain."},{"key":"795_CR25","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1210\/jcem-51-6-1359","volume":"51","author":"JC Gallagher","year":"1980","unstructured":"Gallagher JC, Riggs BL, Deluca HF. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab. 1980;51:1359\u201364.","journal-title":"J Clin Endocrinol Metab"},{"key":"795_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4103\/2230-8210.95684","volume":"16","author":"S Imtiaz","year":"2012","unstructured":"Imtiaz S, Raza S, Muhammad A, Siddiqui N, Loya A. Vitamin D deficiency in newly diagnosed breast cancer patients. Indian J Endocrinol Metab. 2012;16:409\u201313.","journal-title":"Indian J Endocrinol Metab"},{"key":"795_CR27","doi-asserted-by":"publisher","first-page":"S6-4","DOI":"10.1158\/0008-5472.SABCS12-S6-4","volume":"72","author":"R Coleman","year":"2012","unstructured":"Coleman R, Rathbone E, Marshall H, Wilson C, Brown J, Gossiel F, et al. Vitamin D, but not bone turnover markers, predict relapse in women with early breast cancer: an AZURE translational study. Cancer Res. 2012;72:S6-4.","journal-title":"Cancer Res"},{"key":"795_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.maturitas.2010.10.006","volume":"68","author":"RT Chlebowski","year":"2011","unstructured":"Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg CL, Wactawski-Wende J, et al. 25-Hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women. Maturitas. 2011;68:73\u20138.","journal-title":"Maturitas."},{"issue":"6","key":"795_CR29","first-page":"934","volume":"30","author":"B Villaggio","year":"2012","unstructured":"Villaggio B, Soldano S, Cutolo M. 1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. Clin Exp Rheumatol. 2012;30(6):934\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"795_CR30","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/ejcn.2012.82","volume":"66","author":"RE Grossmann","year":"2012","unstructured":"Grossmann RE, Zughaier SM, Liu S, Lyles RH, Tangpricha V. Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr. 2012;66:1072\u20134.","journal-title":"Eur J Clin Nutr"},{"key":"795_CR31","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.4065\/78.12.1463","volume":"78","author":"GA Plotnikoff","year":"2003","unstructured":"Plotnikoff GA, Quigley JM. Prevalence of severe Hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003;78:1463\u201370.","journal-title":"Mayo Clin Proc"},{"key":"795_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Medical progress: Vitamin D deficiency. N Engl J Med. 2007;357:266\u201381.","journal-title":"N Engl J Med"},{"key":"795_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10549-011-1911-6","volume":"132","author":"S Singh","year":"2012","unstructured":"Singh S, Cuzick J, Mesher D, Richmond B, Howell A. Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole. Breast Cancer Res Treat. 2012;132:625\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"795_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10549-009-0495-x","volume":"119","author":"QJ Khan","year":"2010","unstructured":"Khan QJ, Reddy PS, Kimler BF, Sharma P, Baxa SE, O\u2019Dea AP, et al. Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat. 2010;119:111\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"795_CR35","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10549-012-2013-9","volume":"133","author":"D Prieto-Alhambra","year":"2012","unstructured":"Prieto-Alhambra D, Servitja S, Javaid MK, Garrig\u00f3s L, Arden NK, Cooper C, et al. Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study. Breast Cancer Res Treat. 2012;133:1159\u201367.","journal-title":"Breast Cancer Res Treat"},{"key":"795_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10549-011-1644-6","volume":"129","author":"AL Rastelli","year":"2011","unstructured":"Rastelli AL, Taylor ME, Gao F, Armamento-Villareal R, Jamalabadi-Majidi S, Napoli N, et al. Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial. Breast Cancer Res Treat. 2011;129:107\u201316.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"795_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10549-016-3710-6","volume":"155","author":"AC Shapiro","year":"2016","unstructured":"Shapiro AC, Adlis SA, Robien K, Kirstein MN, Liang S, Richter SA, et al. Randomized, blinded trial of vitamin D3for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS). Breast Cancer Res Treat. 2016;155(3):501\u201312.","journal-title":"Breast Cancer Res Treat"},{"key":"795_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10549-017-4429-8","volume":"166","author":"QJ Khan","year":"2017","unstructured":"\u2022\u2022 Khan QJ, Kimler BF, Reddy PS, Sharma P, Klemp JR, Nydegger JL, et al. Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial. Breast Cancer Res Treat. 2017; This is a randomized, placebo-controlled trial of 160 patients, which failed to show benefit for high dose vitamin D in aromatase inhibitor-induced arthralgia.;166:491\u2013500.","journal-title":"Breast Cancer Res Treat"},{"key":"795_CR39","doi-asserted-by":"crossref","unstructured":"Niravath, P, Wang, T, Hilsenbeck, SG, Lipscomb, K, Pavlick, A, Jiralerspong, S, Nangia, J, Ellis, M, Ademuyiwa, F, Cherian M, Frith, A, Ma C, Park H, Rigden C, Suresh R, Osborne CK, Rimawi M. A randomized, controlled trial of high dose vs standard dose vitamin D for aromatase inhibitor-induced arthralgia in breast cancer survivors. San Antonio Breast Cancer Symp. 2018.","DOI":"10.1158\/1538-7445.SABCS18-PD6-02"},{"key":"795_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clbc.2017.10.009","volume":"18","author":"P Niravath","year":"2018","unstructured":"Niravath P, Chen B, Chapman JAW, Agarwal SK, Welschhans RL, Bongartz T, et al. Vitamin D levels, vitamin D receptor polymorphisms, and inflammatory cytokines in aromatase inhibitor-induced Arthralgias: an analysis of CCTG MA.27. Clin Breast Cancer. 2018;18:78\u201387.","journal-title":"Clin Breast Cancer"},{"key":"795_CR41","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1200\/JCO.2005.07.097","volume":"23","author":"PE L\u00f8nning","year":"2005","unstructured":"L\u00f8nning PE, Geisler J, Krag LE, Erikstein B, Bremnes Y, Hagen AI, et al. Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer. J Clin Oncol. 2005;23:5126\u201337.","journal-title":"J Clin Oncol"},{"key":"795_CR42","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa032312","volume":"349","author":"P Goss","year":"2003","unstructured":"Goss P, EIngle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy in early stage breast cancer. N Engl J Med. 2003;349:1793\u2013802.","journal-title":"N Engl J Med"},{"key":"795_CR43","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1200\/JCO.2014.57.1547","volume":"33","author":"ML Irwin","year":"2015","unstructured":"Irwin ML, Cartmel B, Gross CP, Ercolano E, Li F, Yao X, et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol. 2015;33:1104\u201311.","journal-title":"J Clin Oncol"},{"key":"795_CR44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1200\/JCO.2017.74.6651","volume":"36","author":"NL Henry","year":"2018","unstructured":"Henry NL, Unger JM, Schott AF, Fehrenbacher L, Flynn PJ, Prow DM, et al. Randomized, multicenter, placebo-controlled clinical trial of duloxetine versus placebo for aromatase inhibitor-associated arthralgias in early-stage breast cancer: SWOG S1202. J Clin Oncol. 2018;36:326\u201332.","journal-title":"J Clin Oncol"},{"key":"795_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10549-009-0692-7","volume":"120","author":"K Briot","year":"2010","unstructured":"Briot K, Tubiana-Hulin M, Bastit L, Kloos I, Roux C. Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study. Breast Cancer Res Treat. 2010;120:127\u201334.","journal-title":"Breast Cancer Res Treat"},{"key":"795_CR46","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1200\/JCO.2014.59.5595","volume":"33","author":"DL Hershman","year":"2015","unstructured":"Hershman DL, Unger JM, Crew KD, Awad D, Dakhil SR, Gralow J, et al. Randomized multicenter placebo-controlled trial of omega-3 fatty acids for the control of aromatase inhibitor - induced musculoskeletal pain: SWOG S0927. J Clin Oncol. 2015;33:1910\u20137.","journal-title":"J Clin Oncol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-019-0795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-019-0795-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-019-0795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T23:38:07Z","timestamp":1586993887000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-019-0795-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1007\/s11912-019-0795-1","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]},"assertion":[{"value":"17 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Kartik Anand and Polly Niravath declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"51"}}